For NASH treatment, they work by reducing liver fat, improving insulin sensitivity, and promoting weight loss
For comparative studies with native GLP-1, include DPP-IV inhibitors in all assay buffers when native GLP-1 is included as a comparator to prevent rapid DPP-IV degradation that would confound Semaglutide versus native GLP-1 concentration-response comparisons
The study found no increase in pancreatic cancer risk with GLP-1RA use, and several sensitivity analyses suggested a modest, non-significant reduction in incidence (Wang et al., 2025)
Previous analysis has found that survey mode had little impact on major statistics such as annual premiums, contributions, and deductibles
Also known as a growth hormone-releasing factor and GRF 1-29, it is categorized as a growth hormone secretagogue, a compound that stimulates increased secretion of growth hormone from the pituitary gland